Amgen Inc financial data

Symbol
AMGN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
One Amgen Center Drive, Thousand Oaks, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 141 % -44.8%
Quick Ratio 42 % +34.8%
Return On Equity 68.5 % -46.9%
Return On Assets 4.55 % -49.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 538M shares +0.44%
Common Stock, Shares, Outstanding 538M shares +0.45%
Entity Public Float 119B USD -8.76%
Weighted Average Number of Shares Outstanding, Basic 537M shares +0.37%
Weighted Average Number of Shares Outstanding, Diluted 542M shares +0.74%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 32.5B USD +21.2%
Costs and Expenses 26.3B USD +46.4%
Operating Income (Loss) 6.22B USD -29.8%
Nonoperating Income (Expense) 1.69B USD -28.5%
Income Tax Expense (Benefit) 449M USD -62.1%
Net Income (Loss) Attributable to Parent 4.23B USD -44.1%
Earnings Per Share, Basic 7.88 USD/shares -44.3%
Earnings Per Share, Diluted 7.81 USD/shares -44.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.01B USD -74.1%
Accounts Receivable, after Allowance for Credit Loss, Current 7.32B USD +19.1%
Inventory, Net 7.36B USD +46.5%
Other Assets, Current 3.08B USD +19.9%
Assets, Current 26.8B USD -44.8%
Property, Plant and Equipment, Net 6.16B USD +10.7%
Operating Lease, Right-of-Use Asset 651M USD +12.4%
Intangible Assets, Net (Excluding Goodwill) 28.9B USD +120%
Goodwill 18.7B USD +20.3%
Other Assets, Noncurrent 10.4B USD +32.5%
Assets 90.9B USD +0.39%
Accounts Payable, Current 2.15B USD +58.1%
Employee-related Liabilities, Current 1.38B USD +25.7%
Accrued Liabilities, Current 14.6B USD +3.2%
Liabilities, Current 20.3B USD +19.8%
Deferred Income Tax Liabilities, Net 1.71B USD
Operating Lease, Liability, Noncurrent 691M USD +28.2%
Other Liabilities, Noncurrent 2.2B USD -4.6%
Common Stocks, Including Additional Paid in Capital 33.4B USD +1.95%
Accumulated Other Comprehensive Income (Loss), Net of Tax -336M USD -167%
Retained Earnings (Accumulated Deficit) -25.5B USD -2.24%
Stockholders' Equity Attributable to Parent 7.53B USD -1.69%
Liabilities and Equity 90.9B USD +0.39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 689M USD -35.2%
Net Cash Provided by (Used in) Financing Activities -1.71B USD -108%
Net Cash Provided by (Used in) Investing Activities -217M USD -116%
Common Stock, Shares Authorized 2.75B shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.24B USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.01B USD -74.1%
Deferred Tax Assets, Valuation Allowance 957M USD +33.3%
Deferred Tax Assets, Gross 5.51B USD +55.8%
Operating Lease, Liability 810M USD +16.5%
Payments to Acquire Property, Plant, and Equipment 230M USD -33.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.02B USD -50.3%
Lessee, Operating Lease, Liability, to be Paid 977M USD +25.1%
Property, Plant and Equipment, Gross 15.7B USD +7.06%
Operating Lease, Liability, Current 119M USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 121M USD +11%
Lessee, Operating Lease, Liability, to be Paid, Year One 138M USD -19.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +37%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 167M USD +94.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 109M USD +36.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 4.01B USD +6.42%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95M USD +35.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4.72B USD +69.5%
Depreciation, Depletion and Amortization 1.4B USD +55.4%
Deferred Tax Assets, Net of Valuation Allowance 4.55B USD +61.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%